Lloyd K, Newman LA, Glass C, Ogayo ER, et al. Assessing racial disparities in disease outcomes of patients with high-risk, triple-negative breast cancer and residual disease after neoadjuvant therapy: a post-hoc analysis of the ECOG-ACRIN 1131 clinical trial. Breast Cancer Res Treat 2025 Aug 4. doi: 10.1007/s10549-025-07798.
PMID: 40759832